US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

36.62

+2.447.14%

Volume:756.45K

Turnover:27.19M

Market Cap:4.92B

PE:-10.52

High:37.10

Open:34.85

Low:34.57

Close:34.18

52wk High:49.70

52wk Low:10.46

Shares:134.37M

Float Shares:129.97M

Volume Ratio:1.25

T/O Rate:0.58%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4823

EPS(LYR):-2.0600

ROE:-64.09%

ROA:-20.64%

PB:5.36

PE(LYR):-17.78

Loading ...

Overview Company News Filings

U.S. Stocks on the MOVE-SpaceX, Humana, Delta Air Lines

JPMorgan Initiates Coverage on Definium Therapeutics With Overweight Rating, $84 Price Target

MT Newswires Live

Definium up as J.P.Morgan Starts with 'overweight' Rating on LSD-Based Therapy

Definium Therapeutics Shares up 4% Premarket After JP Morgan Initiates Coverage with Overweight Rating

THOMSON REUTERS

Definium Therapeutics Inc : JP Morgan Initiates Coverage with Overweight Rating; Target Price $84

THOMSON REUTERS

Definium Therapeutics Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since January 2024

Analysts’ Top Healthcare Picks: ArriVent BioPharma, Inc. (AVBP), Definium Therapeutics (DFTX)

Definium Therapeutics Issues Inducement Stock Options for 334,810 Shares to New Hires

Analysts Offer Insights on Healthcare Companies: Contineum Therapeutics, Inc. Class A (CTNM) and Definium Therapeutics (DFTX)

Definium Therapeutics Issues Inducement Stock Options to New Hires

Definium Therapeutics Logs Third Positive Phase 3 Readout for DT120 in Anxiety

China's Lepu Biopharma H1 Revenue Rises 12.1% on Higher Drug Sales

Stifel Nicolaus Reaffirms Their Buy Rating on Definium Therapeutics (DFTX)

Definium Therapeutics is Maintained at Buy by Canaccord Genuity

U.S. Research Roundup-Eli Lilly, McDonald's, Welltower

UK's ImmuPharma Interim Net Loss Widens on Derivative Finance Loss

UK's ValiRx Half-Year Loss Narrows, Cash Position Improves

Kestra Medical Technologies Q1 Revenue Beats Estimates, Raises FY Revenue Outlook

Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs

Definium Therapeutics price target raised to $91 from $75 at BofA

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/DFTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":36.62,"timestamp":1791559174307,"preClose":34.18,"halted":0,"volume":756446,"delay":0,"changeRate":0.07138677589233464,"floatShares":129971489,"shares":134366950,"eps":-3.482311,"marketStatus":"Trading","change":2.44,"latestTime":"10-09 11:19:35 EDT","open":34.85,"high":37.1,"low":34.5701,"amount":27188887.139672,"amplitude":0.074017,"askPrice":36.68,"askSize":8,"bidPrice":36.55,"bidSize":382,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":34.18,"preHourTrading":{"tag":"盘前","latestPrice":34.86,"preClose":34.18,"latestTime":"09:29 EDT","volume":8156,"amount":289205.96924,"timestamp":1791552599999,"change":0.68,"changeRate":0.019895,"amplitude":0.061147},"postHourTrading":{"tag":"盘后","latestPrice":34.4969,"preClose":34.18,"latestTime":"19:57 EDT","volume":36874,"amount":1260530.4461,"timestamp":1791503879344,"change":0.3169,"changeRate":0.009272,"amplitude":0.009272},"volumeRatio":1.246966,"impliedVol":0.6351,"impliedVolPercentile":0.0543},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":129971489,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":1.246966,"shares":134366950,"dividePrice":0,"high":37.1,"amplitude":0.074017,"preClose":34.18,"low":34.5701,"week52Low":10.4646,"pbRate":"5.36","week52High":49.7,"institutionHeld":0,"latestPrice":36.62,"committee":0.958974,"eps":-3.482311,"divideRate":0,"volume":756446,"delay":0,"ttmEps":-3.482311,"open":34.85,"prevYearClose":13.39,"prevWeekClose":37.4,"prevMonthClose":38.06,"prevQuarterClose":38.06,"fiveDayClose":37.4,"twentyDayClose":38.89,"sixtyDayClose":44.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-10-08","current":-10.538978,"percent":0.417582,"low":-27.074722,"twenty":-17.041551,"median":-11.678904,"eighty":-9.948453,"high":-8.802064,"avg":-13.976636,"sd":5.118646,"marketCap":4714936275},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-04","current":-14.432336,"twenty":-17.33018,"median":-11.139168,"eighty":-9.901443,"marketCap":5105944100},{"date":"2026-09-11","current":-14.329791,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"marketCap":5069665023},{"date":"2026-09-18","current":-14.690599,"twenty":-17.210941,"median":-11.23988,"eighty":-9.921368,"marketCap":5197313626},{"date":"2026-09-25","current":-13.949992,"twenty":-17.164605,"median":-11.372203,"eighty":-9.935823,"marketCap":4935298073},{"date":"2026-10-02","current":-14.280417,"twenty":-17.093203,"median":-11.537867,"eighty":-9.941944,"marketCap":5052197320},{"date":"2026-10-08","current":-13.327123,"twenty":-17.041551,"median":-11.678904,"eighty":-9.948453,"marketCap":4714936275}],"updateTime":1791556297380},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674859274","title":"U.S. Stocks on the MOVE-SpaceX, Humana, Delta Air Lines","url":"https://stock-news.laohu8.com/highlight/detail?id=2674859274","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674859274?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:57","pubTimestamp":1791547027,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-SpaceX, Humana,Delta Air LinesOct 9 (Reuters)-US stock index futures rose on Friday as oil prices retreated on easing Middle East supply concerns, though telecom shares re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nL6N45V0LD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362540622.SGD","LU0211328371.USD","IE00BSNM7G36.USD","LU0170899867.USD","LU0345780950.USD","SGXZ81514606.USD","LU2271345857.HKD","LU1066051498.USD","LU1037948541.HKD","LU0795875086.SGD","AUMI","LU0868494617.USD","LU0788109121.HKD","LU0949170772.SGD","LU2461242641.AUD","LU1074936037.SGD","LU0058720904.USD","JETS","LU1023059493.AUD","SG9999014013.SGD","LU0708995401.HKD","SG9999014906.USD","IE00BJJMRX11.SGD","LU0882574055.USD","IE0004445239.USD","SGDM","LU0786609619.USD","LU1718418525.SGD","LU2133065610.SGD","LU0683600562.USD","LU2098885051.SGD","LU0965509283.SGD","LU2125154778.USD","LU1934455194.USD","LU2362541273.HKD","LU0029864427.USD","GB00BDT5M118.USD","IE00BJJMRY28.SGD","LU0077335932.USD","LU0048584097.USD","IE00BKPKM429.USD","DAL","LU0208291251.USD","LU0256863811.USD","LU0496367417.USD","LU1548497426.USD","LU0348723411.USD","LU0267386448.USD","IE00B19Z9P08.USD","LU0314106906.USD","LU0266512473.USD","LU0251142724.SGD","IE00B1XK9C88.USD","BK4585","IE0005OL40V9.USD","IE00BFXG1179.USD","LU2211815571.USD","BK4522","LU1064131342.USD","LU1430597077.USD","LU2456880835.USD","LU0316494557.USD","LU2498475776.HKD","XLV","LU1035773651.USD","LU2384288077.EUR","LU0820561909.HKD","LU1093756325.SGD","AGMI","LU1066053197.SGD","LU1674673691.USD","SPCQ","LU0320765059.SGD","LU0345770308.USD","UNHG","LU1551013342.USD","LU0859254822.USD","BK4566","LOFF","GDOC","IE00B3T34201.USD","LU1861215975.USD","LU1934455277.USD","AUAU","MARS","LU1323610961.USD","LU1854104046.USD","LU0912757837.SGD","GLDN","LU0234572021.USD","LU1267930227.SGD","LU1069347547.HKD","IE00B19Z8X17.USD","LU1061106388.HKD","LU1084165304.USD","LU0079474960.USD","LU0158827948.USD","LU2462611646.USD","ELOL","LU1223082196.USD","LU1316542783.SGD","LU2247934214.USD","VHT","LU0943347566.SGD","IYH","LU1778281490.HKD","LU0107464264.USD","SSPC","IE00BZ9MQY76.HKD","LU2089284900.SGD","BK4532","LU2125154935.USD","RXL","LU1291159041.SGD","LU0075056555.USD","LU2290526834.HKD","LU0820561818.USD","LU2264538146.SGD","LU0143863784.USD","LU0251132253.USD","LU0545039389.USD","ORBX","LU0353189763.USD","LU2089984988.USD","LU1861220033.SGD","LU0496365809.HKD","UNH","LU0557290698.USD","SG9999014914.USD","LU0300736062.USD","SG9999001176.USD","SPCF","JDOC","BK4534","LU1506573853.SGD","LU0300736492.USD","DFTX","LU0289739699.SGD","LU1621767810.EUR","LU2250418816.HKD","LU2089283258.USD","FHLC","IE00B775SV38.USD","IE00B19Z9505.USD","LU0149725797.USD","LU1791710400.SGD","IE0004445015.USD","LU0211331839.USD","LU0368265764.SGD","LU0630314457.HKD","LU1102505929.USD","LU0203345920.USD","LU1720051017.SGD","LU1119994496.HKD","UNHW","LU0127658192.USD","LU0128525689.USD","BK4154","LU0320765489.SGD","LU0820562030.AUD","LU0661504455.SGD","LU0122379950.USD","LU1732800096.USD","LU2357305700.SGD","SG9999014021.USD","LU0310800965.SGD","FXH","BK4588","LU0162691827.USD","LU0528227936.USD","SG9999018857.SGD","LU0128525929.USD","LU0742534661.SGD","LU0310799852.SGD","LU0061474705.USD","BK4132","LU0354030438.USD","LU0965508806.USD","BK4017","SPAL","LU2279689827.SGD","IE00BMPRXR70.SGD","LU2210149790.SGD","UN","LU1621768206.USD","IE00B4R5TH58.HKD","LU1720051108.HKD","LU2210150020.SGD","LU2242649171.HKD","LU0390134368.USD","LU1868837565.USD","LU0795875169.SGD","LU0965509101.SGD","LU0672654240.SGD","GDX","LU1267930490.SGD","LU1153585028.USD","LU2095319765.USD","LU1066051811.HKD","IE00BMPRXQ63.HKD","LU1861558580.USD","BK4561","LU2111349929.HKD","LU0738911758.USD","LU0055631609.USD","LU2361045086.USD","LU0345770993.USD","LU0654597011.USD","BK4515","LU0345780521.USD","NWMX","WARP","LU0640476718.USD","LU0011850046.USD","SPCH","LU0942090050.USD","LU0456854461.SGD","LU2491049909.HKD","SGXZ51526630.SGD","IE00B19Z9Z06.USD","IE00BWXC8680.SGD","LU1988902786.USD","IE00B4JS1V06.HKD","LU1989771016.USD","LU0861579265.USD","BK4533","LU2361044865.SGD","LU1093756168.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","SG9999014005.SGD","LU0070302665.USD","LU0724618789.USD","LU2317271919.USD","LU2360032135.SGD","LU0053666078.USD","AU","IE00B775H168.HKD","IE00BZ1G4Q59.USD","LU0612318385.USD","AFK","LU1861559042.SGD","LU1621767737.EUR","LU1934455863.HKD","LU0114720955.EUR","LU2462591277.SGD","LU2491050154.USD","LU2357627491.SGD","BK4549","LU0976567544.SGD","HUM","LU0109391861.USD","IE00B19Z8W00.USD","SGXZ57979304.SGD","LU1057294990.SGD","LU0052756011.USD","LU1003077747.HKD","LU1280957306.USD","LU1674673428.USD","LU0708994859.HKD","SG9999002224.SGD","UNHU","LU2236285917.USD","LU0310800379.SGD","LU0097036916.USD","LU1037948897.HKD","LU0048573561.USD","SG9999013999.USD","LU2324357040.USD","LU0276348264.USD","LU1261432733.SGD","LU2552382215.SGD","TRUH","SPCM","LU1303367103.USD","LU0187121727.USD","LU0354030511.USD","IE00B7KXQ091.USD","BK4581","IE00BJT1NW94.SGD","LU2417539215.USD","LU1854103824.USD","LU0266512127.USD","IE00B19Z3B42.SGD","LU0787776722.HKD","LU1670627923.USD","LU1914381329.SGD","LU2954938101.SGD","SPAX","DSPC","LU0965509010.AUD","TMUS","HRTS","SG9999014880.SGD","GDMN","LU2999663052.SGD","LU0868494708.USD","LU2552382132.HKD","LU0342679015.USD","SG9999014898.SGD","BK4570","LU1102505762.USD","LU0788108826.HKD","LU0612318971.USD","SG9999001143.SGD","LU2468319806.SGD","LU2360107168.USD","LU0056508442.USD","LU0143863198.USD","SLVP","IHF","LU1223083913.SGD","LU0158827781.USD","SGXZ31699556.SGD","LU2087625088.SGD","LU0498741114.HKD","BK4007","LU0330918003.SGD","LU1791710582.SGD","LU1814569148.SGD","SNK","IE00B3S45H60.SGD","LU0211327993.USD","LU1023059063.AUD","IE0009355771.USD","BK4500","LU2244417387.USD","LU1621768115.EUR","SG9999002232.USD","TRUM","TMED","SPCG","LU2552382058.USD","LU2362541513.USD","LU1066051225.USD","LU2347655156.SGD","LU0198837287.USD","IE00BFSS7M15.SGD","SGXZ99366536.SGD","LU0211326839.USD","LU0498741890.SGD","LU0266013472.USD","SPCU","NEM","LU1267930730.SGD","IE0002141913.USD","SPCX","BK4008","SG9999018865.SGD","LU0251131958.USD","IE0002270589.USD","NEMG","LU0456855351.SGD","SG9999017495.SGD","IE00B19Z3581.USD","LU0553294199.USD","LU0203347892.USD","LU1883866441.USD","IE00BFSS8Q28.SGD","LU0689472784.USD","FMTL","LU0143551892.USD","SG9999001176.SGD","LU2360106780.USD","LU0238689110.USD","LU0823416689.USD","SUNH0main","LU0094547139.USD","LU1551013425.SGD","LU1670628061.USD","IE00BFMHRM44.USD","WSPC","LU0642271901.SGD","IE00B1BXHZ80.USD","LU1223082519.USD","LU1732799900.SGD","LU0345780281.USD","LU2361044949.HKD","LU1983299246.USD","LU0303823156.USD","LU2023251221.USD","LU2028103732.USD","LU2112291526.USD","LU1496350502.SGD","IE00BKVL7J92.USD","BK4089","LU0432979614.USD","LU2491050071.SGD","LU1868838027.USD","IE00BN29S564.USD","LU0303821028.USD","IE000M9KFDE8.USD","LU0072461881.USD","LU0353189680.USD","LOFD","LU1267930573.SGD","BK4559","IE00B7SZLL34.SGD","IE00B894F039.SGD","LU1983260115.SGD","LU0345781412.USD","LU0417517546.SGD","LU1852331112.SGD","LU0211326755.USD","IE00BMPRXN33.USD","LU0278409577.USD","YSPC","MHIP","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674313859","title":"JPMorgan Initiates Coverage on Definium Therapeutics With Overweight Rating, $84 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2674313859","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674313859?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:33","pubTimestamp":1791545608,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) has an average rating of buy and mean price target of $65.69, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PGF","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674858428","title":"Definium up as J.P.Morgan Starts with 'overweight' Rating on LSD-Based Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2674858428","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674858428?lang=en_us&edition=fundamental","pubTime":"2026-10-09 18:00","pubTimestamp":1791540028,"startTime":"0","endTime":"0","summary":"BUZZ-Definium up as J.P.Morgan starts with 'overweight' rating on LSD-based therapy** Shares of Definium TherapeuticsDFTX.Orise 4.2% to $35.60 premarket** J.P.Morgan initiates coverage with an \"overwe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nL4N45V0NH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674305188","title":"Definium Therapeutics Shares up 4% Premarket After JP Morgan Initiates Coverage with Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2674305188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674305188?lang=en_us&edition=fundamental","pubTime":"2026-10-09 17:31","pubTimestamp":1791538281,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nL4N45V0N4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674283757","title":"Definium Therapeutics Inc : JP Morgan Initiates Coverage with Overweight Rating; Target Price $84","url":"https://stock-news.laohu8.com/highlight/detail?id=2674283757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674283757?lang=en_us&edition=fundamental","pubTime":"2026-10-09 17:05","pubTimestamp":1791536742,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nFWN45V0PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674002963","title":"Definium Therapeutics Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since January 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2674002963","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674002963?lang=en_us&edition=fundamental","pubTime":"2026-10-09 02:50","pubTimestamp":1791485400,"startTime":"0","endTime":"0","summary":"Definium Therapeutics, Inc.  is currently at $34.56, down $0.53 or 1.51%--Would be lowest close since June 18, 2026, when it closed at $24.48--On pace for largest percent decrease since Oct. 6, 2026, when it fell 1.68%--Currently down 11 of the past 12 days--Currently down eight consecutive days; down 10.02% over this period--Longest losing streak since Jan. 19, 2024, when it fell for eight straight trading days--Worst eight day stretch since the eight days ending Sept. 9, 2026, when it fell 13.3%--Down 9.2% month-to-date--Up 158.1% year-to-date; on pace for best year since 2020, when it rose 580.8%--Down 76.96% from its all-time closing high of $150.00 on March 17, 2017--Up 176.48% from 52 weeks ago , when it closed at $12.50--Down 28.67% from its 52-week closing high of $48.45 on July 9, 2026--Up 223.6% from its 52-week closing low of $10.68 on Nov. 21, 2025--Traded as low as $32.84; lowest intraday level since June 18, 2026, when it hit $23.80--Down 6.41% at today's intraday low; la","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673509465","title":"Analysts’ Top Healthcare Picks: ArriVent BioPharma, Inc. (AVBP), Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673509465","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673509465?lang=en_us&edition=fundamental","pubTime":"2026-10-07 17:50","pubTimestamp":1791366612,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ArriVent BioPharma, Inc. (AVBP), Definium Therapeuti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-arrivent-biopharma-inc-avbp-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-arrivent-biopharma-inc-avbp-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","AVBP","BK4588","BK4007","BK4139","XLV","LU0029874061.USD","BK4585","HCSG","XBI","BK4137","LABU","BK4581","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671172257","title":"Definium Therapeutics Issues Inducement Stock Options for 334,810 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2671172257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671172257?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:01","pubTimestamp":1790625696,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues inducement stock options for 334,810 shares to new hiresDefinium Therapeutics issued inducement option grants covering 334,810 common shares to 15 newly hired non-executiv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL1nPLsh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668905145","title":"Analysts Offer Insights on Healthcare Companies: Contineum Therapeutics, Inc. Class A (CTNM) and Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668905145","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668905145?lang=en_us&edition=fundamental","pubTime":"2026-09-19 22:40","pubTimestamp":1789828824,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Contineum Therapeutics, Inc. Class A (CTNM) and Defi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-contineum-therapeutics-inc-class-a-ctnm-and-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-contineum-therapeutics-inc-class-a-ctnm-and-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0029874061.USD","LU0128526141.USD","CTNM","BK4007","BK4581","BK4588","HCSG","LABU","XLV","DFTX","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668793185","title":"Definium Therapeutics Issues Inducement Stock Options to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2668793185","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668793185?lang=en_us&edition=fundamental","pubTime":"2026-09-17 07:09","pubTimestamp":1789600153,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) has shared an update. Definium Therapeutics has granted stock options to three newly hired non-executive employee...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-issues-inducement-stock-options-to-new-hires-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-issues-inducement-stock-options-to-new-hires-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668071939","title":"Definium Therapeutics Logs Third Positive Phase 3 Readout for DT120 in Anxiety","url":"https://stock-news.laohu8.com/highlight/detail?id=2668071939","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668071939?lang=en_us&edition=fundamental","pubTime":"2026-09-17 07:08","pubTimestamp":1789600138,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) has shared an announcement. Definium Therapeutics reported positive topline results from its Panorama Phase 3 tri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-logs-third-positive-phase-3-readout-for-dt120-in-anxiety?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-logs-third-positive-phase-3-readout-for-dt120-in-anxiety?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667761606","title":"China's Lepu Biopharma H1 Revenue Rises 12.1% on Higher Drug Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2667761606","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667761606?lang=en_us&edition=fundamental","pubTime":"2026-09-16 16:42","pubTimestamp":1789548131,"startTime":"0","endTime":"0","summary":"China's Lepu Biopharma H1 revenue rises 12.1% on higher drug salesOverviewChina oncology therapeutics developer's H1 2026 revenue grew 12.1% yr/yrDomestic commercialization revenue more than doubled, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL1N45807H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0972486137.USD","LU2125909593.SGD","LU1355424745.HKD","LU2433249047.HKD","IE00B2B36J28.USD","03165","LU0640478417.SGD","BK5011","LU0499090636.EUR","LU0882574055.USD","LU1153584641.USD","LU0047473722.SGD","LU0128525929.USD","LU1323610961.USD","IE0034235188.USD","LU0920840948.USD","LU1061106388.HKD","LU0784385170.HKD","LU1267930813.SGD","LU2089984988.USD","IE00BJT1NW94.SGD","IE00BKPKM643.USD","LU1267930573.SGD","LU2355687059.USD","LU0052756011.USD","LU1989772923.USD","LU1003076772.USD","LU0310800379.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","LU1196032939.SGD","LU0211327993.USD","LU1496350171.SGD","LU0997586432.USD","DFTX","LU1496350502.SGD","LU1481600234.SGD","LU1170363599.USD","02157","LU0889566641.SGD","IE00B3T34201.USD","BK1161","LU1119994496.HKD","LU0976567544.SGD","LU2125909247.SGD","LU1301847155.USD","LU0128525689.USD","LU0114720955.EUR","AZN.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667391679","title":"Stifel Nicolaus Reaffirms Their Buy Rating on Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667391679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667391679?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:05","pubTimestamp":1789524333,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Definium Therapeutics yesterday and set a price target of $67.00. According to TipR...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628789","title":"Definium Therapeutics is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628789","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628789?lang=en_us&edition=fundamental","pubTime":"2026-09-15 22:25","pubTimestamp":1789482300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667261429","title":"U.S. Research Roundup-Eli Lilly, McDonald's, Welltower","url":"https://stock-news.laohu8.com/highlight/detail?id=2667261429","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667261429?lang=en_us&edition=fundamental","pubTime":"2026-09-15 15:19","pubTimestamp":1789456752,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Eli Lilly, McDonald's, WelltowerSept 15 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Eli Lilly, M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570I2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKV","PPL","CAKE","DOC","RMD","LIF","GLW","BWIN","DFTX","WELL","ASTH","RIVN","SRRK","VC","HR","MIDD","RBLX","SMST","THRM","RWR","THO","VTR","ENVA","VSH","NKE","DAVE","SYK","CRDF","LYNX","AAON","BSX","RBLY","USRT","DT","MSTR","SPCX","MCD","LEA","LLY","ZBRA","PLAY","IBP","RBLU","AGL","SYM","ULTA","JAN","NTSK","CNP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667619028","title":"UK's ImmuPharma Interim Net Loss Widens on Derivative Finance Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2667619028","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667619028?lang=en_us&edition=fundamental","pubTime":"2026-09-15 14:16","pubTimestamp":1789452975,"startTime":"0","endTime":"0","summary":"UK's ImmuPharma interim net loss widens on derivative finance lossOverviewUK drug developer's interim net loss widened to 4.7 mln on derivative finance lossOperating loss for the half-year narrowed sl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL1N457064:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IMM.UK","DFTX","BK5011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667619035","title":"UK's ValiRx Half-Year Loss Narrows, Cash Position Improves","url":"https://stock-news.laohu8.com/highlight/detail?id=2667619035","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667619035?lang=en_us&edition=fundamental","pubTime":"2026-09-15 14:15","pubTimestamp":1789452938,"startTime":"0","endTime":"0","summary":"UK's ValiRx half-year loss narrows, cash position improvesOverviewUK cancer therapeutics developer's half-year loss narrowed, administrative expenses reducedCompany's cash position improved after June","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL1N45705L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693077","title":"Kestra Medical Technologies Q1 Revenue Beats Estimates, Raises FY Revenue Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693077","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693077?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:12","pubTimestamp":1789416751,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Q1 revenue beats estimates, raises FY revenue outlookOverviewUS wearable medical device maker's fiscal Q1 revenue grew 60%, beating analyst expectationsAdjusted EBITDA loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL1N4560UB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX","BK4082","SRRK","BK4139","THNR","KMTS","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693327","title":"Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693327?lang=en_us&edition=fundamental","pubTime":"2026-09-15 03:30","pubTimestamp":1789414223,"startTime":"0","endTime":"0","summary":"UPDATE 2-Experts urge FDA to set clear safety and access standards for psychedelic drugsSept 14 (Reuters)-Doctors, veterans, pharmacists and therapists on Monday urged the U.S. Food and Drug Administr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL1N4560R3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4539","BK4007","ATAI","DFTX","GHRS","CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667670066","title":"Definium Therapeutics price target raised to $91 from $75 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2667670066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667670066?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:30","pubTimestamp":1789403417,"startTime":"0","endTime":"0","summary":"BofA raised the firm’s price target on Definium Therapeutics (DFTX) to $91 from $75 and keeps a Buy rating on the shares. Definium reported positiv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-91-from-75-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-91-from-75-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}